ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2013

A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.

Muneer H Abidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.